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The MEF2 family of transcription factors has been implicated in transcriptional regulation in a number of different cell
types. Targeted deletion of the MEF2C gene, in particular, revealed its importance for early cardiogenesis (Q. Lin et al., 1997,
cience 276, 1404–1407). We report here that this deletion also resulted in vascular anomalies characterized by extreme
ariability in lumen size and defects in remodeling. While primary vascular networks formed in the yolk sac of the mutants,
hey failed to remodel into more complex vascular structures. Likewise, although the primordia of the dorsal aortae formed
ormally, anomalies were observed in these vessels later in development. Dorsal and anterior to the heart, the aortae
xhibited abnormally small lumens, as did the anterior cardinal veins and intersegmental arteries. In contrast, the dorsal
ortae and intersegmental arteries caudal to the heart were grossly enlarged. Cranial vessels were also enlarged and less
ranched than normal. Endocardiogenesis in the mutant was abnormal with the endothelial cells exhibiting a number of
berrant phenotypes. These endocardial defects were accompanied by a notable reduction in angiopoietin 1 and VEGF
RNA production by the myocardium, indicating that MEF2C is required for myocardial expression of these important
ndothelial-directed cytokines and thus for correct endocardial morphogenesis. © 1999 Academic Press
Key Words: cardiovascular development; MEF2; angiopoietin 1; VEGF.INTRODUCTION
Vascular development is a complicated process requiring
the coordinated actions of many genes. The overall process
can be divided into two components. The first is vasculogen-
esis in which angioblasts, the precursors of endothelial cells,
establish a primitive vascular network. This phase of vessel
morphogenesis involves the establishment of the endothelial
lineage, the aggregation of angioblast into cord-like assem-
blies, and the formation of the vessel lumen. The primitive
polygonal networks that are formed through vasculogenesis
are then remodeled to form a more mature vascular architec-
ture (for review see Drake et al., 1998). This second phase of
vascular morphogenesis is most closely associated with the
1 To whom correspondence should be addressed at the Division
of Cardiology, Department of Internal Medicine, University of
Texas Medical School at Houston, 6431 Fannin, Houston, TX
77030. Fax: (713) 500-6547. E-mail: jschwarz@heart.med.uth.tmc.edu.
0012-1606/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.process of angiogenesis, the formation of new vessels from
preexisting vessels. The remodeling phase is likely to involve
a number of processes: vascular sprouting and pruning, fusion
of small caliber vessels to form large vessels, and intussuscep-
tion in which sinuses are converted into networks. As the
vasculature matures, small vessels are surrounded by peri-
cytes, whereas larger vessels are surrounded by smooth
muscle cells. These cells provide structural support and nec-
essary paracrine signals to the endothelial cells (Risau, 1997;
Risau and Flamme, 1995).
Although the mechanisms regulating vasculogenesis and
angiogenesis are far from clear, a general outline has
emerged from the analysis of targeted deletions of vascular-
related genes. Key among these are those encoding
endothelial-restricted receptors and their ligands. It was
found that early endothelial differentiation and vasculogen-
esis requires VEGF (vascular endothelial growth factor) and
its receptors Flk1 and Flt1 (Fong et al., 1995; Shalaby et al.,
1995; Ferrara et al., 1996; Carmeliet et al., 1996a,b).
255
1
t
c
T
o
t
p
d
c
(
1
h
b
e
t
u
e
c
e
L
p
t
i
t
(
t
(
V
c
b
v
b
a
n
a
i
i
b
o
m
256 Bi, Drake, and SchwarzThe actions of VEGF and its receptors (Flk1 and Flt1) in
vascular development have been extensively investigated.
As the deletion phenotypes of VEGF and its receptors differ,
it is likely that these receptors have additional ligands,
likely of the same family (Olofsson et al., 1996; Kull et al.,
996; Achen et al., 1998). Additionally, VEGF itself binds to
he unrelated receptor, neuropilin, which possibly also
ontributes to the distinct phenotypes (Soker et al., 1998).
hese phenotypic differences are most apparent for deletion
f Flk1, which blocks endothelial cell differentiation prior
o vessel formation. Loss of this gene also blocks hemato-
oiesis, thus it may be required for both lineages indepen-
ently or may arrest the development of the hemangioblast
ell that is believed to be the precursor to both lineages
Shalaby et al., 1995; Choi et al., 1998; Eichmann et al.,
998).
In contrast to this early block in differentiation, mice
omozygous null for VEGF are still able to produce angio-
lasts that form small vessels in the posterior region of the
mbryo. Remarkably, loss of VEGF also produces the con-
rasting phenotype of extremely large anterior vessels. So,
nlike Flk1, VEGF is not essential for establishing the
ndothelial lineage or early differentiation of endothelial
ells, but appears to be required after the vessel structure is
stablished (Carmeliet et al., 1996a; Ferrara et al., 1996).
oss of the other VEGF receptor, Flt1, yields a different
henotype entirely. Although vessels are assembled in
TABLE 1
Primer Sets Used for RT/PCR
Gene Primers
b-actin GGACCTGGCTGGCCGGGACC
GCGGTGCACGATGGAGGGGC
MEF2C GGGATCCAACACGGGGACTATGGGG
GGCCATGGTGCGGCTCGTTGTACTC
VEGF GCCGTCCTGTGTGCCGCTGATG
GCCCTCCGGACCCAAAGTGCTC
Flk1 AGAACACCAAAAGAGAGGAACG
GCACACAGGCAGAAACCAGTAG
Flt1 TGTGGAGAAACTTGGTGACCT
TGGAGAACAGCAGGACTCCTT
Flt4 CACCGAAGCAGACGCTGATGAT
AGCTGCTGTCTGCGAAGAAGGT
Ang1 GGCACGGAAGGCAAGCGCTG
CAAGCATGGTGGCCGTGTGG
Tie1 GGGTGGTGCTGGCGCGCGGC
CCAGAGGGGCAGACGCAGCC
Tie2 AAGACATACGTGAACACCACACT
ACTCTAGAGTCAGAACACACTGCAG
EPAS1 TGCCACCTCCCCAGCCACCATC
GGCCACTGCTTGGTGACCTGGChese mice, they exhibit malformations in their lumens,
.e., the presence of endothelial cells. These data suggest
Copyright © 1999 by Academic Press. All righthat Flt1 is required for proper organization of the lumen
Fong et al., 1995).
Angiopoietin 1, its receptor Tie2, and the related recep-
or Tie1 appear to be required in vascular remodeling
Suri et al., 1996; Dumont et al., 1994; Sato et al., 1995).
ascular anomalies in these mice include decreased
omplexity of the cranial vasculature, evident by lack of
ranching and the dilation of some vessels. Moreover, the
asculature of the yolk sac fails to remodel into a
ranching network of large and small vessels. The Tie2
nd Ang1 knockout mice also exhibit a decrease in the
umber of pericytes surrounding vessels in the head. The
bsence of such cells may account for the aberrant
nteractions between endothelial cells and the surround-
ng mesenchyme observed in these mice. Decreased num-
ers of pericytes surrounding vessels have also been
bserved in several other mutants. These include null
utations in PDGF-B (Lindahl et al., 1997), Tgf-b1 (Dick-
son et al., 1995), tissue factor (Carmeliet et al., 1996b),
and the thrombin receptor (Connolly et al., 1996). How-
ever, the lack of pericytes is confined to the yolk sac for
all these mutants except the PDGF-B null in which
pericytes are deficient around embryonic capillaries.
These phenotypes indicate the existence of a paracrine
relationship between endothelial cells and the surround-
ing mesoderm or mesenchyme. For the Tie2 and Ang1
mutants, these relationships are most pronounced in the
Product length
(bp)
Annealing temperature
(°C)
583 72
254 65
536 72
382 58
505 62
461 65
413 65
696 62
258 53
432 72AG
GG
ATheart where their loss causes endocardial malformations
and failure of the myocardium to form trabeculae. Such
s of reproduction in any form reserved.
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257MEF2C Is Required for Vascular Developmentreciprocal interactions appear necessary for formation of
mature vessels composed of endothelial cells surrounded
by pericytes, smooth muscle, or myocardium. Precise
FIG. 1. Whole-mount immunohistochemistry to PECAM of E9.5 e
) Normal embryos and (D, E, and F) MEF2C homozygous null em
omplex branching in comparison with the normal head vessels sho
ith extreme dilation of the dorsal aorta and intersegmental arteri
eart is much smaller and irregularly shaped in the mutant (E) com
rteries in this region are also constricted. DA, dorsal aorta; IS, in
IG. 2. Hematoxylin and eosin staining of normal (A through D
henotypes of different vascular beds. (A) Yolk sac vessels havin
nd mesoderm. These layers are separated in the mutant, lead
ild-type (B) and mutant (F) heads showing the enlarged endo
ransverse sections at the level of the heart with normal paired
utant, there is only a single, small dorsal aorta visible and
onstricted, whereas the endocardial cells are rounded in the m
here the dorsal aortae in the mutant are greatly enlarged comp
ortic sac; E, endoderm; CV, cardinal vein; LV, left umbilical ve
V, right umbilical vein; V, ventricle; VA, vitelline artery.regulations of these paracrine relationships are required
such that altering them through removal of either recep-
g
f
Copyright © 1999 by Academic Press. All rightors or ligands results in abnormal angiogenesis (Maison-
ierre et al., 1997).
Members of the MEF2 family of transcription factors are
yos showing the complex vascular defects in the mutant. (A, B, and
os. D shows the dilated head vessels in the mutant and their less
n A. The vessels caudal to the heart are also enlarged in the mutant
, normal and F, mutant). In contrast, the dorsal aorta dorsal to the
d to the wild type (B). The aortic arch arteries and intersegmental
mental artery.
d MEF2C-null (E through F) embryos shows the distinct mutant
ormal capillary network with tight association of the endoderm
o the appearance of pools of blood (E). Parasagittal sections of
al lined cavity in front of the optic vesicle of the mutant. (C)
al aortae and cardinal veins in the wild-type embryo. (G) In the
cardinal veins are missing. The ventricle is hypoplastic and
t. (H) The opposite phenotype is observed caudal to the heart
to the wild type (D). A, atrium; AA, first aortic arch artery; AS,
, mesoderm; OV, optic vesicle; PVP, perioptic vascular plexus;mbr
bry
wn i
es (C
pare
terseg
) an
g a n
ing t
theli
dors
the
utanood candidates for regulators of vessel development. This
amily is composed of four members that are distinguished
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258 Bi, Drake, and Schwarzfrom a larger family of MADS box transcription factors by a
MEF2 homology domain located adjacent to the MADS box
(Martin et al., 1993; McDermott et al., 1993). These genes
are expressed in cardiac, skeletal, and vascular smooth
muscle cells; endothelial cells; several types hematopoietic
cells; and discrete neurons of the central nervous system
(Edmondson et al., 1994; Lyons et al., 1995; Firulli et al.,
1996; Swanson et al., 1998; Lin et al., 1998). Several lines of
vidence have implicated members of this family in tran-
criptional regulation of muscle-specific genes and of genes
egulated by extracellular signals (Olson et al., 1995). The
trongest evidence for their importance in muscle-specific
ranscription comes from null mutations in Drosophila in
hich loss of the single MEF2 gene blocks differentiation of
ardiac, skeletal, and visceral muscle (Lilly et al., 1995;
our et al., 1995). Targeted deletion of the MEF2C gene in
he mouse does not cause as dramatic a muscle phenotype,
ut does result in loss of the right ventricle of the heart,
ailure of the remaining ventricle to loop, and reduced
xpression of some cardiac-specific genes (Lin et al., 1997).
Here we report that deletion of MEF2C also resulted in a
omplex set of vascular malformations. These vascular
alformations included the arrest of yolk sac vascular
evelopment as a capillary network and the eventual dis-
uption of the yolk sac vessels. The head vessels were
nlarged and have a simpler branching architecture. There
as extreme enlargement of the dorsal aortae and interseg-
ental arteries caudal to the heart. However, the dorsal
ortae, cardinal veins, and aortic arch arteries near the heart
ere constricted. The endothelial cells of the endocardium
ere rounded and had an erratic orientation with respect to
he myocardium. Moreover, cardiac expression of Ang1 and
EGF was dramatically reduced, likely causing the ob-
erved endocardial anomalies. Thus MEF2C appears to be
equired for normal vascular development and is possibly a
irect, or indirect, transcriptional regulator of Ang1 and
EGF in the myocardium.
METHODS
Mice and Embryos
Genotyping of pups and embryos was done by PCR amplification
of DNA isolated from the tail or the yolk sac, respectively, using
previously described primers (Lin et al., 1997). Because the cardiac
efect is 100% penetrant, during later stages of this research the
mbryos were not genotyped but instead homozygous-null em-
ryos were selected based on the cardiac phenotype. The gesta-
ional age of the embryos was determined by setting E0.5 at noon
n the morning that a vaginal plug was observed.
Whole-Mount Immunohistochemistry to PECAM
Whole-mount immunohistochemistry with a rat monoclonal anti-
body to the mouse PECAM (MEC13.3 from Pharmingen) for light
microscopy was performed as described previously (Schlaeger et al.,
1995). Either horseradish peroxidase- or alkaline phosphatase-coupled
anti-rat IgG secondary antibodies were used for detection.
Copyright © 1999 by Academic Press. All rightImmunolabeling to PECAM for laser scanning confocal micro-
scopic analysis was accomplished by the following procedures.
Embryos were dissected free of the decidua and the ectoplacental
cone was removed. The flattening procedure was done in a 35-mm
plastic petri dish filled with PBS. First a tear was made in the
amniotic sac and the sac gently opened. This was followed by
making two cuts in the extraembryonic yolk sac, parallel to the
embryonic axis. One cut was directed toward the head and the
other toward the allantois. The dissected embryo was then flat-
tened with the endodermal side upward. This was achieved by
gently pressing the extraembryonic ectoderm against the plastic
until it adhered. Once flat, the embryos were fixed by the slow
addition of 3% paraformaldehyde to the PBS. After initial fixation
was achieved, the majority of the PBS/3% paraformaldehyde mix-
ture was removed and fresh 3% paraformaldehyde added (total
fixation time was 15 min). After three washes in PBS, embryos
were permeabilized in 0.02% Triton X-100 in PBS for 30 min
followed by an additional three washes in PBS. After the mouse
embryos had been flattened and fixed, they were immunolabeled
and processed as previously described for avians (Drake et al.,
997).
In Situ Hybridization
In situ hybridization was done essentially as previously de-
scribed (Lyons et al., 1995). The mouse VEGF probe (obtained from
Dr. Celeste Simon) was cloned into the pCR2.1 plasmid in both
orientations. Sense and antisense riboprobes were produced by first
linearizing with HindIII and then transcribing with T7 polymerase.
In situ hybridizations of normal and mutant embryos were exposed
to emulsion and photographed for equal amounts of time so that
the hybridization signal could be directly compared.
Semiquantitative RT/PCR
The primers and gene products are listed in Table 1. Flk1 and
Tie2 primers are from Fong et al. (1995) and Flt1 and Flt4 primers
are from Shalaby et al. (1995). The PCR products shown in Fig. 5
were each from the RNA of one embryo. Those in Fig. 6 were from
RNA isolated from a set of three hearts. The RT/PCR procedure
was essentially the same as described previously (Lin et al., 1997)
except that 2 mg of total RNA was used to produce the cDNA used
or subsequent PCR.
RESULTS
The Extraembryonic Vasculature Failed to Mature
The first indication that abrogation of the MEF2 gene
affected vascular morphogenesis was the observation that
vascular development in the yolk sac was abnormal. The
vasculature in this region lacked the large vitelline vessels
that are characteristic of the E9.0 embryo. Additional evi-
dence of compromised extraembryonic vascular develop-
ment was the defective vascular connections between the
yolk sac and the embryo. The vitelline vein connecting to
the sinus venosus was hypoplastic and contained no blood
cells. Likewise, blood was rarely observed in the vitelline
artery or the umbilical artery or vein and then only in the
most embryo proximal part.
s of reproduction in any form reserved.
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259MEF2C Is Required for Vascular DevelopmentThe development of the yolk sac vasculature is often used
as an indicator of correct vascular morphogenesis. As part of
vascular morphogenesis in this region, a uniform network
of capillary-like vessels that are referred to as the primary
vascular networks is remodeled into a more complex vas-
culature of diversely sized vessels. In MEF2C nulls, this
reorganization never occurred. Instead, pools of blood in
large, poorly defined vessels were observed. Sectioning
through these vessels revealed that the blood pools formed
as a consequence of the endodermal and mesodermal layers
of the yolk sac separating (Figs. 2A and 2E). Separation of
these layers has been reported in several mice with targeted
deletions. For the tissue factor knockout in particular, this
FIG. 3. The dorsal aortae form normally in MEF2C-null embryos.
mmunofluorescence laser scanning confocal images of whole-
ount embryos labeled with antibodies to PECAM were taken to
isualize the early vascular system. The images were generated by
ompressing a series of optical sections onto a single focal plane
hat represents the entire intraembryonic vasculature as viewed
rom the ventral surface. Comparison of the vasculature of the E8.0
ild type (A) to its MEF2C-null littermate (B) reveals that vascu-
ogenesis as monitored by the development of the dorsal aortae
roceeds normally in the mutant. In contrast, the endocardium of
he mutant, while not obviously abnormal, is retarded compared to
he normal littermate. DA, dorsal aortae. AIP, anterior intestinal
ortal.separation is accompanied by loss of the periendothelial
cells that support the endothelial cells (Carmeliet et al.,
Copyright © 1999 by Academic Press. All right1996b). We therefore examined the mutant yolk sacs for
periendothelial cells by electron microscopy and immuno-
histochemistry with an antibody to smooth muscle a-actin,
but failed to detect any differences in the numbers of these
cells (data not shown). From these observations, we con-
clude that the genesis of periendothelial cells associated
with vessels in the yolk sac of the MEF2C null was normal.
The Embryonic Vasculature Had Severe and
Diverse Malformations
We next examined vascular morphogenesis within the
embryo using antibodies directed against the endothelial
protein, PECAM (platelet endothelial cell adhesion mole-
cule), to visualize the vasculature (Schlaeger et al., 1995).
This analysis revealed a complex set of vascular malforma-
tions at day E9.5. The predominant feature of these alter-
ations was an abnormal variability in vessel diameter. The
major vessels in the head and tail of the mutants had
increased-sized lumens, whereas those dorsal and rostral to
the heart had small lumens. The enlargement of cranial
vessels in MEF2-null embryos was evident when the PE-
CAM staining pattern in the mutant (Fig. 1D) was com-
pared to a wild-type littermate (Fig. 1A). Associated with
the enlargement of the vessels was a loss of vascular
complexity. In the normal embryo, these vessels exhibit
complexity in both branching pattern and lumen size. The
vessels of the mutant were more uniform in size and
exhibited less branching. Alterations in vascular diameter
could be quite dramatic and included large endothelial-
lined cavities in front of the optic vesicles (Fig. 2F). The
dorsal aortae caudal to the heart were also greatly enlarged.
An extreme example of this enlargement can be seen in Fig.
1F, in which the dorsal aortae and intersegmental arteries
were enlarged to such an extent that they nearly filled the
mesenchymal space ventral to the somites and neural tube.
This was also apparent in sections in which the dorsal
aortae were enlarged and the mesenchymal component was
correspondingly decreased (Fig. 2H). There was also an
apparently decreased number of capillaries visible by PE-
CAM immunohistochemistry. It is unclear at this time if
fewer organized capillaries were detectable because they
have regressed or if they have fused with other vessels and
thus contributed to vessel enlargement.
A remarkably distinct vascular phenotype was observed
in the vessels dorsal and immediately rostral to the heart.
Whereas the dorsal aortae caudal to the heart of mutants
were much larger than the corresponding wild type, those
in the region of the heart were very small and irregularly
shaped (Fig. 1E). In addition, they formed a winding path
that often appeared to contain discontinuities. This could
most clearly be seen in sections in which the dorsal aortae
were so small as to be virtually indistinguishable from the
surrounding mesenchyme (Fig. 2G). The intersegmental
arteries that branch off from the dorsal aortae in this region
were also comparatively small and malformed. Moreover,
they appeared to end shortly after branching rather than
s of reproduction in any form reserved.
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260 Bi, Drake, and Schwarzcontinuing between the somites (Fig. 1E). The aortic arch
arteries were likewise much smaller than normal.
As judged by visual inspection, the distribution and
number of red blood cells in the null embryos was abnor-
mal. Variable amounts of blood were seen in 69% (70/102)
of the embryos at E9.5; but there were only trace amounts
in many cases. This blood was concentrated in the atrium
and sinus venosus (63% of total embryos) and large lacunae
in the tail (45%). Only a small number (10%) contained
blood in cavities in front of the optic vesicles. Remarkably,
no trace of blood was observed in 31% of the embryos at
E9.5, suggesting that the integration of the extraembryonic
and intraembryonic vascular beds necessary to form a
unified circulatory system did not occur.
Vasculogenesis of the Dorsal Aortae Was Normal
The distinct phenotypes of vessels dorsal and caudal to
the heart led us to inquire if vasculogenesis was different in
these two regions or if later events led to the distinct
phenotypes. We examined serial sections of dorsal aortae
from normal and mutant embryos at the early looping stage
to determine if there were any differences in vasculogen-
esis. No obvious differences were observed in the size of the
vessel at this stage (data not shown). However, because it is
difficult to determine the overall patterning of vessels in
serial sections, we also examined vascular development in
the intact embryo. Using a protocol developed specifically
to study the earliest stages of mouse vasculogenesis (C.J.D.
and P. Flemming, submitted for publication), embryos were
dissected and fixed in a manner that rendered the normally
curved mouse embryo into a planar orientation. The vascu-
lature of the embryo was then visualized using PECAM
antibody and laser scanning confocal microscopy. Embryos
were subjected to optical sectioning and the sections were
then collapsed to generate a single image depicting the
entire embryonic vasculature. When vascular development
in mutants was compared to normal littermates using this
method, no differences were observed in the development
of the primitive dorsal aortae of normal (Fig. 3A) and the
mutant (Fig. 3B), suggesting that vasculogenesis, at least of
the primary vascular network and the dorsal aortae, was
normal and that the observed vascular differences arose
later in development. However, comparison of the endocar-
dial development of the normal and mutant embryos (Figs.
3A and 3B) revealed clearly altered endocardial develop-
ment in the mutant (Fig. 3B). Most apparent was the failure
or retardation of looping and the abnormal morphogenesis
of the most anterior portions of the endocardium. Two
abnormal vascular structures were evident anteriorly (Fig.
3B; arrowheads). Based on position and connection with the
carotid arteries, these abnormal structures were most
closely associated with the aortic arches and the ventral
aorta. While the MEF2C-null hearts exhibited abnormal
development in this region, in more caudal regions, endo-
cardial morphogenesis appears more normal. Apparently
normal populations of endocardial precursor cells were
Copyright © 1999 by Academic Press. All rightvident in association with the well-defined anterior intes-
inal portal (AIP). This observation suggests that there was
nitial vasculogenesis in the heart-forming regions and that
hese fields were translocated to the midline by processes
ssociated with the AIP.
The Endocardium Was Malformed
FIG. 4. The endothelial cells of the endocardium are malformed
and have an irregular orientation relative to the myocardium. Hema-
toxylin and eosin staining of a normal (A) ventricle shows the
extended shape of normal endothelial cells and their uniform orien-
tation to the myocardium. The endothelial cells of the mutant (B) are
rounded and clumped together (arrows). The endocardium is collapsed
between the left ventricle and the outflow tract (arrowhead), and the
endothelial cells also have an irregular orientation with respect to the
myocardium (asterisk). In C and D, the phenotypes of normal (C) and
mutant (D) endocardia as viewed by LSCM are compared. Both hearts
were immunolabeled with antibodies to PECAM and were viewed
from the ventral surface. In the normal heart (C), the contour of the
endocardium is relatively smooth, and in general, there are few
endocardial projections outward to the myocardium. In contrast, the
contour of endocardium of the mutant embryos is rough in appear-
ance. Numerous small projections extending from the endocardium
disrupt the contour of the endocardium, giving it a “spiky” appear-
ance. The disruption of normal endothelial development is also
evident from the relative absence of visible individual cell boundaries
in the mutant (D) that are pronounced in the normal (C). A, atrium;
EC, endothelial cells; V, ventricle.The endocardium is a unique vascular structure that is
formed from bilateral vascular networks. In a complex
s of reproduction in any form reserved.
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the midline and fuse to form a large single vessel sur-
rounded by the myocardium. With the completion of these
morphogenic events, the heart is usually viewed as an
endocardial tube within an outer myocardial tube. To
further explore the endocardial defects revealed at E8.5, we
examined the structure of the endocardium of normal and
null embryos at E9.5 in sections. Endothelial cells compos-
ing the endocardium in normal embryos were well spread
and appeared as a smooth, uniform inner lining of the heart
(Fig. 4A). In contrast, the endothelial cells of the mutant
endocardium were rounded, without extended cytoplasms
(Fig. 4B). They also did not form a smooth inner lining, but
were instead irregularly oriented with respect to the myo-
cardium (Fig. 4B; asterisk). The endocardial lumen also
appeared to be severely constricted at the junction between
the ventricle and the outflow tract (Figs. 4B and 4D). This
FIG. 5. Semiquantitative RT/PCR on selected endothelial-specific
genes and growth factors. Expression of several genes required for
normal vascular development was assayed by RT/PCR. Each sample
was from the RNA of one embryo. RNA either from the entire embryo
or from an embryo with the heart removed was used. Hearts were
removed to determine expression in the remainder of the embryo
without differential expression in the malformed hearts obscuring any
differences in the rest of the embryo. Reduced expression of the tested
genes was not detected, but VEGF expression was increased.phenotype was associated with an apparent increase in the
extracellular matrix referred to as the cardiac jelly (Fig. 4B).
Copyright © 1999 by Academic Press. All righthese endocardial alterations resembled those produced by
ull mutations in Ang1 or its receptor, Tie2 (Sato et al.,
1995; Suri et al., 1996) and by the exogenous expression of
the Ang1 antagonist, Ang2, in endothelial cells (Maisonpi-
erre et al., 1997), suggesting possible defects in the Ang1/
Tie2 signaling system.
To investigate further the structure of the mutant endo-
cardium, we examined embryos in which the endocardium
was visualized with an antibody to PECAM and laser
scanning confocal microscopy (LSCM). The view of the
endocardium provided by this technique allowed us to
better interpret the relationship between the endocardium
and the myocardium. Comparison of the mutant endocar-
dium (Fig. 4D) to that of the normal (Fig. 4C) showed that
the mutant endocardium lacked the uniform contour of the
normal. Additionally, the pronounced PECAM staining at
cell boundaries visible in the normal endocardium was
FIG. 6. In situ hybridization shows increased amounts of VEGF in
he mutant embryo at E9.5. Normal and mutant embryos at E8.5
nd E9.5 were assayed for VEGF expression by in situ hybridiza-
ion. At E8.5 the greatest amount of VEGF expression is in the
trophoblast giant cells and in the foregut of the embryos. There
appears to be no difference between the mutant and the wild type
in these regions (A and B). The levels in the rest of the embryo are
very low by this method and any differences between the normal
(A) and the mutant (B) embryos cannot be distinguished. At E9.5,
VEGF expression in the normal embryo is highest in the branchial
arch and at lower levels throughout the embryo (C). The mutant
embryo displays very high levels of VEGF mRNA in the somites,
neural tissue, and heart (D). This embryo exhibits signs of necrosis
and was likely hypoxic. A, atrium; BA, branchial arch; FG, foregut;
GC, trophoblast giant cell; S, somites; V, ventricle.
s of reproduction in any form reserved.
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262 Bi, Drake, and Schwarzmissing in the mutant. The lack of strong PECAM expres-
sion at sites of cell–cell contact is consistent with the
rounded, bunched-up appearance of these cells by light
microscopy and may reflect decreased cell–cell adhesion
(Fig. 4B). The erratic orientation of endothelial cells in the
mutant was evident in whole mounts as endothelial cell
projections that jutted outward toward the myocardium.
The presence of these projections suggests that the mutant
endocardium, especially in the ventricle, formed with less
regard to the surrounding myocardium, as if the normal
organizational signals were not being exchanged between
these two cell types. The disrupted contour of the endocar-
dium may also have resulted from the failure of the initial
endothelial networks to reorganize into a single, large
lumen. A careful examination of endocardial development
in the mutant will be necessary to determine if this is the
case.
Genes Important for Vascular Formation Were
Expressed Relatively Normally in the Mutant
Embryo but Not in the Mutant Heart
In considering the above data, one possible cause of the
observed vascular defects could be the lack of proper signal-
ing between the endothelial cells and the surrounding
mesoderm. In an attempt to define the molecular link
between these two cell populations, we compared mRNA
levels for endothelial-restricted receptors and their ligands
in the normal and mutant by semiquantitative RT/PCR.
Primary candidates were the endothelial-directed cytokines
(VEGF and Ang1), the endothelial-restricted receptors (Flk1,
Flt1, Flt4, Tie1, Tie2), and the endothelial-restricted tran-
scription factor EPAS1 (Dumont et al., 1994; Fong et al.,
1995; Shalaby et al., 1995; Ferrara et al., 1996; Tian et al.,
FIG. 7. Semiquantitative RT/PCR reveals a severe decrease in
angiopoietin 1 and VEGF expression in the mutant hearts. RT/PCR
amplification of RNA isolated from three hearts of E9.5 embryos
was used to make cDNA for each PCR. These embryos were
younger than the E9.5 embryos in Fig. 6, so that developmental
expression of these cytokines would be assayed and not their
induction by long-term hypoxia. The mRNA for each sample was
normalized to the amount of b-actin mRNA determined by RT/
PCR and then used for amplification of Ang1 or VEGF.997). Possible changes in expression of VEGF and Ang1
ere of greatest interest because of the similarities between
Copyright © 1999 by Academic Press. All righthe vascular phenotype of the MEF2C null and the VEGF,
ie2, and Ang1 nulls. In both the MEF2C- and the VEGF-
ull mice, the dorsal aortae are small or absent near the
eart but enlarged posteriorly (MEF2C) or anteriorly (VEGF)
Ferrara et al., 1996; Carmeliet et al., 1996). Comparison of
the MEF2C null with mice having mutations of the Ang1/
Tie2 signaling pathway also revealed similarly rounded
endocardial cells and collapse of the endocardium (Suri et
al., 1996; Dumont et al., 1994; Sato et al., 1995; Maisonpi-
erre et al., 1997). Because the endocardium is a major source
of endothelial-restricted receptors and the myocardium is a
major source of their cognate ligands, we were concerned
that the severe cardiac malformations of the MEF2C null
would confound our interpretation of any alterations in
their expressions in the rest of the embryo. Therefore,
expression of these genes was assayed using the RNA either
from complete E9.5 embryos or from embryos in which the
hearts were removed. As can be seen in Fig. 5, the expres-
sion was relatively consistent between these two sources of
RNA and there were not pronounced decreases in the
amounts of all tested genes between normal and mutant
embryos. Moreover, the amount of VEGF was actually
increased slightly in the mutant. This was probably caused
by hypoxia in the nonperfused embryo, leading to upregu-
lation of VEGF (Iyer et al., 1998). It is also of note that,
although expression of MEF2C is highest in the heart at this
stage by in situ hybridization (Edmondson et al., 1994),
there was considerable expression in the remainder of the
embryo detected by RT/PCR, highlighting the ubiquitous
nature of the message.
While mechanisms regulating VEGF expression in the
embryo are unknown, hypoxia has been shown to be a
physiological inducer (Lyer et al., 1998). Considering the
overall vascular phenotype of the MEF2C null, it is reason-
able to conclude that the circulatory system in these
embryos was compromised and consequently the embryo
became increasingly hypoxic. That this may be the case was
indicated by the increase in VEGF mRNA shown in Fig. 5.
To investigate the induction of VEGF indicated by our
RT/PCR results further, we examined the expression of
VEGF by in situ hybridization at two developmental stages:
E8.5 embryos in which the mutant did not appear develop-
mentally retarded and E9.5 embryos in which the mutant
had obvious vascular defects and retardation. The amount
of VEGF mRNA in the E8.5 embryo was highest in the
foregut of both mutant and wild-type embryos with lower
amounts in the heart and the rest of the embryo (Figs. 6A
and 6B). Apart from the foregut, the expression was so low
that we were unable to reliably distinguish differences
between the mutant and the wild-type embryos by this
method. In contrast, the expression in mutant E9.5 embryos
was much higher than in the corresponding wild type. This
increase was most pronounced in the somites, neural tis-
sue, and heart (Figs. 6C and 6D).
To examine the question of cytokine production specifi-
cally in the heart, we isolated hearts from normal and
mutant embryos early on E9.5 for RT/PCR analysis of
s of reproduction in any form reserved.
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263MEF2C Is Required for Vascular DevelopmentVEGF and Ang1 mRNAs. These embryos were large enough
that the hearts could be cleanly isolated from the bodies but
they had not developed obvious signs of necrosis. Our
intention in choosing this time point was to assay the
developmental expression of these cytokines in the heart
and not their induction by severe hypoxia, which causes a
general increase in the amount of VEGF (Fig. 6D). Remark-
ably, the amounts of VEGF and Ang1 mRNAs were signifi-
cantly reduced in the mutant hearts (Fig. 7). Reduced Ang1
expression in the myocardium provides a simple explana-
tion for the similarity of the endocardial defects between
the MEF2C and the Ang1 nulls. Interestingly, the decreased
cardiac VEGF expression at this time point differs from its
later induction throughout the embryo. We interpret this
difference to MEF2C being required for developmental
expression of VEGF in the heart, whereas the later induc-
tion by hypoxia is through HIF1 (Iyer et al., 1998). Thus, the
VEGF needed for normal endocardial formation was defi-
FIG. 8. Model of cardiovascular defects in the MEF2C-null em-
ryo. (A) Circulatory dysfunction causes decreased shear stress on
he endothelial cells and reduced oxygen and nutrients to the
issue. This results in loss of mesenchymal cells and increased
EGF production from hypoxia. The vessels then undergo hyper-
usion to form enlarged lumens or atresia to form smaller than
ormal lumens depending on the location of the vessels. (B)
ormal myocardium produces Ang1 and VEGF that signal through
heir receptors on the endocardial cells to form a smooth endocar-
ial lining of the heart. The endocardium in turn signals to the
yocardium to produce trabeculae. The myocardium of the
EF2C null is deficient in the developmental expression of these
ytokines, so the endocardium is malformed. However, hypoxia
ventually induces VEGF expression in the myocardium.cient in the mutants, probably contributing to the endocar-
dial malformation. The later, generalized increase in VEGF
Copyright © 1999 by Academic Press. All rightin response to hypoxia could contribute to the vascular defects
by promoting fusion of vessels (Drake and Little, 1995).
DISCUSSION
The MEF2C null exhibits a complex set of vascular
malformations that can be broadly classified as alterations
in lumen diameter and failure to reorganize the primitive
network into a more mature branching pattern. Alterations
in lumen diameter varied by location in the embryo. In the
head and caudal to the heart, the lumens were enlarged and
there was a concomitant reduction in the number of capil-
laries visible by PECAM staining. In contrast, the vessels in
the region of the heart had much smaller lumens than
normal and they formed irregular pathways within the
embryo. Remodeling defects were apparent in three areas:
the yolk sac, the head, and the endocardium. Primary
vascular networks of the yolk sac appeared to have formed
normally, but failed to remodel into variably sized, branch-
ing vessels characteristic of a more mature vasculature.
Similarly, the head vessels in the mutant had a primitive,
simpler branching pattern than normal, indicating a failure
in remodeling. The endocardium of null embryos appeared
constricted, and there appeared to be a marked increase in
the extracellular matrix referred to as the cardiac jelly.
Endothelial cells of the endocardium viewed in sections
appeared rounded and erratically oriented, while en face
analysis of whole mounts showed numerous inappropriate
cell projections extending from the endocardium toward
the myocardium. In total the anomalies we observed in the
null embryos’ endocardia suggest that the developmental
relationship between the endocardium and the myocar-
dium was disrupted.
Vascular Defects Probably Resulted from Many
Factors
Several factors must be considered in formulating models
to explain these malformations. The most important of
these is the circulatory dysfunction caused by the cardiac
defects. The most prominent cardiac defects are the missing
right ventricle and the hypoplastic left ventricle. There is
also an accompanying constriction between the outflow
tract and the left ventricle that restricts outward flow (Lin
et al., 1997). By E9.5, these cardiac malformations caused
blood to pulsate upward from the atrium into the left
ventricle and then to flow backward into the atrium.
Although initially of normal sizes, the atrium and sinus
venosus became enlarged later in development. This type of
hypertrophy develops in several zebrafish mutations exhib-
iting ventricular deficiencies and so appears to be a general
response to ventricular dysfunction (Stainier et al., 1995,
1996; Chen et al., 1996). The observation of blood in the
extremities of 69% of the embryos indicates that a func-
tional circulatory system was initially established in most
embryos, but circulation was not maintained as judged by
the complete lack of blood flow in E9.5 embryos. The loss of
s of reproduction in any form reserved.
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264 Bi, Drake, and Schwarzblood flow has numerous consequences to both endothelial
cells and the embryo, among these are the lack of shear
stress and decreased nutrients and oxygen to tissues. These
alterations could either together or individually cause in-
duction of VEGF expression and cell death.
A link between cell loss and vessel enlargement is sug-
gested by reports that enlarged cranial vessels in several
other mutants are associated with loss of mesenchyme (Iyer
et al., 1998; Henkemeyer et al., 1995; Offermanns et al.,
1997; Wang et al., 1998; Choi et al., 1997). As mesenchymal
ells normally provide structural support and paracrine
actors to endothelial cells, their loss could contribute to
essel enlargement from lack of support and possibly to
heir failure to properly remodel from loss of cytokines and
ellular interactions. For the MEF2C null, increased VEGF
xpression in response to hypoxia could be an additional
actor in vessel enlargement.
Many lines of research have shown that proper vessel
ormation is exquisitely sensitive to the amount of VEGF.
his has been observed in mouse mutants that have re-
uced or total absence of VEGF (Carmeliet et al., 1996a;
errara, 1996), in quail embryos treated with exogenous
EGF (Drake and Little, 1995), and in experimental models
f angiogenesis (Benjamin and Keshet, 1997; Springer et al.,
998). One conclusion from these experiments is that
levated amounts of VEGF promote vessel enlargement
hrough fusion of smaller vessels. The fusion model of large
essel formation was first proposed in studies examining
he effects of elevated amounts of VEGF on vasculogenesis
n the quail embryo (Drake and Little, 1995). In this study,
he addition of exogenous VEGF caused the vessels of the
rimary vascular network to undergo unregulated fusion to
orm large, abnormal vascular structures. The vessel en-
argement was concomitant with a loss of the primary
etwork. Similar vessel enlargement was observed in the
EF2 null and, as was the case in quail, was correlated with
he loss of the primary vascular networks. That a causal
elationship exists between increased VEGF expression and
he vessel enlargement observed in the MEF2C null is
upported by our detection of increased VEGF levels by
T/PCR of whole embryos and in situ hybridization (Figs. 5
nd 6). This increased expression in the null was not
pparent during early development (prior to approximately
9.5), but correlated with the growth of the embryo. We
peculate that with increased growth and a compromised
irculatory system the embryo becomes increasingly hy-
oxic (Fig. 6). This hypoxia is a potent inducer of VEGF (Iyer
t al., 1998; Ryan et al., 1998). Thus, a simple model for
essel enlargement (diagramed in Fig. 8) is that circulatory
ysfunction results in hypoxia and lack of nutrients that in
urn cause VEGF induction and death of mesenchymal
upport cells. Under the influence of VEGF, the poorly
upported endothelial cells fuse with the adjacent capillary
etwork to form enlarged vessels.
Although hyperfusion through loss of mesenchymal cellsnd increased expression of VEGF is a plausible mechanism
or vessel enlargement, it does not explain how the vessels
b
l
Copyright © 1999 by Academic Press. All rightear the heart became constricted rather than enlarged.
his constriction occurred even though there appeared to
e an equivalent loss of mesenchyme and increased VEGF
xpression in the areas with vessel enlargement and atresia.
ther factors must therefore be important to determine the
henotype of the vascular malformations in each region of
he embryo. We have considered two possible factors to
xplain these contrasting phenotypes. Both presuppose that
he endothelial cells in the different regions of the embryo
espond oppositely to similar signals.
One possible explanation for the constricted vessels in
he presence of increased VEGF is for VEGF signaling to be
bnormal in the mutant endothelial cells. This could occur
f MEF2C is required for proper VEGF signaling. MEF2C is
nvolved in signal transduction in several cell types (Kato et
l., 1997; Han et al., 1997). It is also expressed in endothe-
ial cells of the embryo (Lin et al., 1998). Moreover, we have
ound that VEGF will activate a promoter through a MEF2
ite in primary endothelial cell cultures and will increase
he ability of MEF2C to activate transcription (W.B. and
.J.S., manuscript in preparation), indicating that MEF2C
an transduce the VEGF signal on some promoters. There-
ore, a possible cause of the vessel atresia is the inability of
ome VEGF-responsive genes to be induced in the MEF2C
ull despite the increased amounts of VEGF. Without
xpression of these VEGF-responsive genes, the vessels
ould regress in a manner similar to the regression of newly
ormed vessels upon removal of VEGF (Benjamin and
eshet, 1997).
Another possible explanation for vessel atresia is that
hese vessels require blood flow to form or maintain a
ormal lumen. Vessel regression is a normal part of vascu-
ar development. Regression can also result from experi-
ental manipulation of blood flow in the embryo. For
nstance, altering blood flow into the aortic arch arteries by
ither constricting the outflow tract or changing the
treams of blood entering the heart from the yolk sac will
ause atresia and other malformations of these arteries
Gesssner, 1966; Hogers et al., 1996). These experiments
uggest that reduced blood flow through the outflow tract
n the MEF2C mutant could cause the observed atresia of
he aortic arch arteries. However, they do not indicate if
ow alterations will also cause the atresia of the dorsal
ortae, intersegmental arteries, and cardinal veins seen in
hese mutants. Further experiments will be necessary to
etermine if these vessels also regress without blood flow.
Like vessel atresia, the failure to remodel the yolk sac
asculature from the primary capillary network into
ranching, variable-sized vessels could also stem from flow
lterations or endothelial dysfunction. Yolk sac vascular
emodeling is extremely responsive to blood flow. For
nstance, the yolk sac capillary plexus will remodel within
inutes of experimental vitelline vein ligation to form new
onnections (Hogers et al., 1996). In addition, normal yolk
ac remodeling initiates near the same time as circulation
egins, suggesting that it may depend on blood flow. So,
ack of blood flow in the MEF2C null at the time when
s of reproduction in any form reserved.
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265MEF2C Is Required for Vascular Developmentnormal remodeling occurs could block maturation. How-
ever, another possibility is that MEF2C provides a neces-
sary function for the yolk sac endothelial cells to remodel.
Yolk sac endothelial cells express MEF2C (Lin et al., 1998),
o it is possible that the endothelial cells are dysfunctional
ithout this gene.
Endocardial Defects Were Probably Caused by
Decreased Cardiac Expressions of Ang1 and VEGF
An important aspect of early heart morphogenesis is the
two-way communication with the endocardium to produce
a uniform endothelial lining. This communication is by
cytokines such as VEGF and Ang1 produced in the myocar-
dium signaling through their cognate endothelial-restricted
receptors to the endocardium. When Ang1 signaling in
particular is blocked from loss of Ang1 or its receptor, Tie2,
the endocardial cells become rounded and the endocardium
collapses. The resulting endocardial dysfunction in turn
causes loss of reciprocal signals to the myocardium, pre-
venting myocyte maturation and trabeculae formation (Suri
et al., 1996; Sato et al., 1995). The endocardial phenotype of
he VEGF-null mouse has not been thoroughly examined.
owever, the myocardium in the VEGF heterozygote was
eported to be blocked in maturation and does not appear to
ave trabeculae (Ferrara et al., 1996), suggesting that the
ndocardial dysfunction from decreased amounts of this
ytokine is also causing a reciprocal malformation in the
yocardium.
Comparing the endocardial phenotypes of the MEF2C,
ng1, and Tie2 mutants, a number of similarities are
vident (Fig. 4; Suri et al., 1996; Sato et al., 1995). The basis
for the similarities we believe lies in our finding that the
amount of Ang1 mRNA was severely decreased in the
MEF2C-null heart (Fig. 7). This observation and the fact
that Ang1 is strongly expressed in the normal heart at this
stage of development supports the notion that the endocar-
dial malformations resulted from an Ang1 deficiency (Suri
et al., 1996). The expression pattern of VEGF was more
complicated (diagramed in Fig. 8). Initially, the amount of
VEGF was much lower in the mutant heart (Fig. 7); suggest-
ing that MEF2C is required for normal cardiac expression of
VEGF. However, as the embryo becomes older, the amount
of VEGF in the heart and the rest of the embryo increased to
greater than normal amounts (Fig. 6). We believe that this
later increase in expression was from hypoxia inducing
VEGF through HIF1 (Iyer et al., 1997; Ryan et al., 1998).
Decreased cytokine expression in the MEF2C null was not
aused by a general decrease in all cardiac-specific genes,
ecause expressions of many examined genes were un-
hanged (Lin et al., 1997; data not shown). Rather, these
cytokines appear to be part of a restricted set of genes that
are not fully expressed in the mutant. The function of
MEF2C in cardiac morphogenesis thus appears to include
endocardial formation through regulating expression of
these important cytokines in the myocardium.
Our analysis of the MEF2C-null phenotype is in general
Copyright © 1999 by Academic Press. All rightagreement with the recent study of Lin and colleagues
(1998). However, there are points on which we differ. The
first is that we believe that initial vasculogenesis in the
MEF2C null is normal and that the observed vessel malfor-
mations arise subsequently from a variety of causes. Sec-
ond, our data suggest that the endocardial defects in this
mutant are caused from decreased amounts of myocardial-
derived VEGF and Ang1.
In summary, loss of MEF2C results in an array of vascular
malformations throughout the embryo and yolk sac that
can be broadly categorized has alterations in lumen size and
defective remodeling. The causes of these malformations
are likely to be multifactorial. Some of these factors are
failure to form a functional circulatory system, loss of
mesenchymal support cells, and alterations in the levels of
Ang1 and VEGF. The relative importance of each of these
factors probably depends of the specific vascular bed in-
volved. Enlarged and possibly hyperfused vessels would
most likely result from loss of mesenchyme and increased
levels of VEGF, whereas vessel atresia would more likely
result from loss of flow or defects in VEGF signaling.
Whichever is the most important factor in the vessel
defects, the most plausible proximate cause of the endocar-
dial defect is the significant decrease in Ang1 and VEGF
expression by the myocardium, suggesting that an essential
function of MEF2C in the myocardium is regulation of
proper expression of these cytokines to direct endocardial
formation. Whether it is a direct transcriptional regulator of
these genes awaits further experimentation.
ACKNOWLEDGMENTS
We express our gratitude to Eric Olson, Mark Majesky, and
Timothy Scott-Burden for many helpful discussions and to Celeste
Simon for the VEGF in situ probe. Michael Blackburn’s assistance
with the photomicroscopy and Paul Fleming’s help with the
confocal microscopy are also greatly appreciated. This research was
supported by grants from the American Heart Association
(9650286N (J.J.S.) and S986515 (C.J.D.)) and the NIH (HL57375
(C.J.D.)).
REFERENCES
Achen, M. G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks,
A. F., Alitalo, K., and Stacker, S. A. (1998). Vascular endothelial
growth factor D (VEGF-D) is a ligand for the tyrosine kinases
VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl.
Acad. Sci. USA 95, 548–553.
Benjamin, L. E., and Keshet, E. (1997). Conditional switching of
vascular endothelial growth factor (VEGF) expression in tumors:
Induction of endothelial cell shedding and regression of
hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl.
Acad. Sci. USA 94, 8761–8766.
Bour, B. A., O’Brien, M. A., Lockwood, W. L., Goldstein, E. S.,
Bodmer, R., Taghert, P. H., Abmayr, S. M., and Nguyen, H. T.
(1995). Drosophila MEF2, and transcription factor that is essen-
tial for myogenesis. Genes Dev. 9, 730–741.
s of reproduction in any form reserved.
266 Bi, Drake, and SchwarzCarmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L.,
Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eber-
hardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau,
W., and Nagy, A. (1996a). Abnormal blood vessel development
and lethality in embryos lacking a single VEGF allele. Nature
380, 435–439.
Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P.,
Vlaenderen, I. V., Demunck, H., Kasper, M., Breier, G., Evrard, P.,
Muller, M., Risau, W., Edgington, T., and Collen, D. (1996b). Role
of tissue factor in embryonic blood vessel development. Nature
383, 73–75.
Chen, J.-N., Haffter, P., Odenthal, J., Vogelsang, E., Brand, M., Van
Eeden, F. J. M., Furutani-Seiki, M., Granato, M., Hammer-
schmidt, M., Heisenberg, C.-P., Jiang, Y.-J., Kane, D. A., Kelsh,
R. N., Mullins, M. C., and Nusslein-Volhard, C. (1996). Muta-
tions affecting the cardiovascular system and other internal
organs in zebrafish. Development 123, 293–302.
Choi, D.-S., Ward, S. J., Messaddeq, N., Launay, J.-M., and Maro-
teaux, L. (1997). 5-HT2B receptor-mediated serotonin morphoge-
netic functions in mouse cranial neural crest and myocardial
cells. Development 124, 1745–1755.
Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C., and
Keller, G. (1998). A common precursor for hematopoietic and
endothelial cells. Development 125, 725–732.
Connolly, A. J., Ishihara, H., Kahn, M. L., Farese, R. V., and
Coughlin, S. R. (1996). Role of the thrombin receptor in devel-
opment and evidence for a second receptor. Nature 381, 516–519.
Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B.,
Karlsson, S., and Akhurst, R. J. (1995). Defective haematopoiesis
and vasculogenesis in transforming growth factor-b1 knock out
mice. Development 121, 1845–1854.
Drake, C. J., and Little, C. D. (1995). Exogenous vascular endothe-
lial growth factor induces malformed and hyperfused vessels
during embryonic neovascularization. Proc. Natl. Acad. Sci.
USA 92, 7657–7661.
Drake, C. J., Brandt, S. J., Trusk, T. C., and Little, C. D. (1997).
TAL1/SCL is expressed in endothelial progenitor cells/
angioblasts and defines a dorsal-to-ventral gradient of vasculo-
genesis. Dev. Biol. 192, 17–30.
Drake, C. J., Hungerford, J. E., and Little, C. D. (1998). Morphogen-
esis of the first blood vessels. In “Annals of the New York
Academy of Science Morphogenesis: Cellular Interactions” (R.
Fleischmajer, R. Timpi, and Z. Werb, Eds.), pp. 155–180. New
York Academy of Science, New York.
Dumont, D. J., Gradwohl, G., Fong, G.-H., Puri, M. C., Gertsen-
stein, M., Auerbach, A., and Breitman, M. L. (1994). Dominant-
negative and targeted null mutations in the endothelial receptor
tyrosine kinase, tek, reveal a critical role in vasculogenesis of the
embryo. Genes Dev. 8, 1897–1909.
Eichmann, A., Corbel, C., Nataf, V., Vaigot, P., Breant, C., and Le
Douarin, N. M. (1997). Ligand-dependent development of the
endothelial and hemapoietic lineages from embryonic mesoder-
mal cells expressing vascular endothelial growth factor receptor
2. Proc. Natl. Acad. Sci. USA 94, 5141–5146.
Edmondson, D. G., Lyons, G. E., Martin, J. F., and Olson, E. N.
(1994). Mef2 gene expression marks the cardiac and skeletal
muscle lineages during mouse embryogenesis. Development
120, 1251–1263.
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea,
K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. (1996).
Heterozygous embryonic lethality induced by targeted inactiva-
tion of the VEGF gene. Nature 380, 439–442.
Copyright © 1999 by Academic Press. All rightFirulli, A. B., Miano, J. M., Bi, W., Johnson, A. D., Casscells, W.,
Olson, E. N., and Schwarz, J. J. (1996). Myocyte enhancer binding
factor-2 expression and activity in vascular smooth muscle cells:
Association with the activated phenotype. Circ. Res. 78, 196–
204.
Flamme, I., von Reutern, M., Drexler, H. C. A., Syed-Ali, S., and
Risau, W. (1995). Overexpression of vascular endothelial growth
factor in the avian embryo induces hypervascularization and
increased vascular permeability without alterations of embry-
onic pattern formation. Dev. Biol. 171, 399–414.
Fong, G.-H., Rossant, J., Gertsenstein, M., and Breitman, M. L.
(1995). Role of the Flt-1 receptor tyrosine kinase in regulating the
assembly of vascular endothelium. Nature 376, 66–70.
Gessner, I. H. (1966). Spectrum of congenital cardiac anomalies
produced in chick embryos by mechanical interference with
cardiogenesis. Circ. Res. 18, 625–632.
Han, J., Jiang, Y., Li, Z., Kravchenko, V. V., and Ulevitch, R. J.
(1997). Activation of the transcription factor MEF2C by the MAP
kinase p38 in inflammation. Nature 386, 296–299.
Henkemeyer, M., Rossi, D. J., Holmyard, D. P., Puri, M. C.,
Mbamalu, G., Harpal, K., Shih, T. S., Jacks, T., and Pawson, T.
(1995). Vascular system defects and neuronal apoptosis in mice
lacking Ras GTPase-activating protein. Nature 377, 695–701.
Hogers, B., DeRuiter, M. C., Gittenberger-de Groot, A. C., and
Poelmann, R. E. (1996). Unilateral vitilline vein ligation alters
intracardiac blood flow patterns and morphogenesis in the chick
embryo. Circ. Res. 80, 473–481.
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E.,
Wenger, R. H., Gassman, M., Gearhart, J. D., Lawler, A. M., Yu,
A. Y., and Semenza, G. L. (1998). Cellular and developmental
control of O2 homeostasis by hypoxia-inducible factor 1a. Genes
Dev. 12, 149–162.
Kato, Y., Kravchenko, V. V., Tapping, R. I., Han, J., Ulevitch, R. J.,
and Lee, J. D. (1997). BMK1/ERK5 regulates serum-induced early
gene expression through transcription factor MEF2C. EMBO J.
16, 7054–7066.
Kull, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M.,
Joukov, V., and Alitalo, K. (1996). VEGF-C receptor binding and
pattern of expression with VEGFR-3 suggests a role in lymphatic
vascular development. Development 122, 3829–3837.
Lilly, B., Zhao, B., Ranganayakulu, G., Paterson, B. M., Shulz, R. A.,
and Olson, E. N. (1995). Requirement of MADS domain tran-
scription factor d-MEF2 for muscle formation in Drosophila.
Science 267, 688–693.
Lin, Q., Schwarz, J. J., and Olson, E. N. (1997). Control of cardiac
morphogenesis and myogenesis by the myogenic transcription
factor MEF2C. Science 276, 1404–1407.
Lin, Q., Lu, J., Yanagisawa, H., Webb, R., Lyons, G. E., Richardson,
J. A., and Olson, E. N. (1998). Requirement of the MADS-box
transcription factor MEF2C for vascular development. Develop-
ment 125, 4565–4574.
Lindahl, P., Johansson, B. R., Leveen, P., and Betsholtz, C. (1997).
Pericyte loss and microaneurysm formation in PDGF-B-deficient
mice. Science 277, 242–245.
Lyons, G. E., Micales, B. K., Schwarz, J., Martin, J. F., and Olson,
E. N. (1995). Expression of mef2 genes in the mouse central
nervous system suggests a role in neuronal maturation. J. Neu-
rosci. 15, 5727–5738.
Maisonpierre, P. C., Suri, C., Jones, P., Bartunkova, S., Wiengand,
S., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.,
Papadopoulos, N., Daly, T., Davis, S., Sato, T., and Yancopoulos,
s of reproduction in any form reserved.
MO
267MEF2C Is Required for Vascular DevelopmentG. (1997). Angiopoietin-2, a natural antagonist for tie2 that
disrupts in vivo angiogenesis. Science 277, 55–60.
Martin, J. F., Schwarz, J. J., and Olson, E. N. (1993). Myocyte
enhancer factor (mef) 2c: A tissue-restricted member of the mef-2
family of transcription factors. Proc. Natl. Acad. Sci. USA 90,
5282–5286.
cDermott, J. C., Cardoso, M. C., Yu, Y. T., Andres, V., Leifer, D.,
Krainc, D., Lipton, S. A., and Nadal-Ginard, B. (1993). Hmef2c
gene encodes skeletal muscle- and brain-specific transcription
factors. Mol. Cell. Biol. 13, 2564–2577.
ffermanns, S., Mancino, V., Revel, J. P., and Simon, M. I. (1997).
Vascular system defects and impaired cell chemokinesis as a
result of Ga13 deficiency. Science 275, 533–536.
Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V.,
Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K., and
Eriksson, U. (1996). Proc. Natl. Acad. Sci. USA 93, 2576–2581.
Olson, E. N., Perry, M., and Schulz, R. A. (1995). Regulation of
muscle differentiation by the MEF2 family of MADS box tran-
scription factors. Dev. Biol. 172, 2–14.
Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671–674.
Risau, W., and Flamme, I. (1995). Vasculogenesis. Annu. Rev. Cell
Dev. Biol. 11, 73–91.
Ryan, H. E., Lo, J., and Johnson, R. S. (1998). HIF-1a is required for
solid tumor formation and embryonic vascularization. EMBO J.
17, 3005–3015.
Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara,
Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., and
Qin, Y. (1995). Distinct roles of the receptor tyrosine kinases tie-1
and tie-2 in blood vessel formation. Nature 376, 70–74.
Schlaeger, T. M., Qin, Y., Fujiwara, Y., Magram, J., and Sato, T. N.
(1995). Vascular endothelial cell lineage-specific promoter in
transgenic mice. Development 121, 1089–1098.
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu,
X.-F., Breitman, M. L., and Schuh, A. C. (1995). Failure of
blood-island formation and vasculogenesis in Flk-1-deficient
mice. Nature 376, 62–66.Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun,
M. (1998). Neuropilin-1 is expressed by endothelial and tumor
Copyright © 1999 by Academic Press. All rightcells as an isoform-specific receptor for vascular endothelial
growth factor. Cell 92, 735–745.
Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M., and Blau,
H. M. (1998). VEGF gene delivery to muscle: Potential role for
vasculogenesis in adults. Mol. Cell 2, 549–558.
Stainier, D. Y. R., Fouquet, B., Chen, J.-N., Warren, K. S., Wein-
stein, B. M., Meiler, S. E., Mohideen, M.-A., Neuhauss, S. C. F.,
Solnica-Krezel, L., Schier, A. F., Zwartkruis, F., Stemple, D. L.,
Malicki, J., Driever, W., and Fishman, M. C. (1996). Mutations
affecting the formation and function of the cardiovascular sys-
tem in the zebrafish embryo. Development 123, 285–292.
Stainier, D. Y. R., Weinstein, B. M., Detrich, H. W., Zon, L. I., and
Fishman, M. C. (195). Cloche, an early acting zebrafish gene, is
required by both the endothelial and hematopoietic lineages.
Development 121, 3141–3150.
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C.,
Davis, S., Sato, T. N., and Yancopoulos, G. D. (1996). Requisite
role of angiopoietin-1, a ligand for the tie2 receptor, during
embryonic angiogenesis. Cell 87, 1171–1180.
Swanson, B. J., Jack, H. M., and Lyons, G. E. (1998). Characteriza-
tion of myocyte enhancer factor 2 (MEF2) expression in B and T
cells: MEF2C is a B cell-restricted transcription factor in lym-
phocytes. Mol. Immunol. 35, 445–458.
Tian, H., McKnight, S. L., and Russell, D. W. (1997). Endothelial
PAS domain protein 1 (EPAS1), a transcription factor selectively
expressed in endothelial cells. Genes Dev. 11, 72–82.
Visvader, J. E., Fujiwara, Y., and Orkin, S. H. (1998). Unsuspected
role for the T-cell leukemia protein SCL/tal-1 in vascular devel-
opment. Genes Dev. 12, 473–479.
Wang, H. U., Chen, Z.-F., and Anderson, D. J. (1998). Molecular
distinction and angiogenic interaction between embryonic arter-
ies and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell
93, 741–753.
Received for publication October 30, 1998
Revised April 20, 1999
Accepted April 20, 1999
s of reproduction in any form reserved.
